Top

BMC Complementary Medicine and Therapies

Published in:

Open Access 01-12-2023 | Leukemia | Research

Biological activities of extracts and compounds from Thai Kae-Lae (Maclura cochinchinensis (Lour.) Corner)

Authors: Lapamas Rueankham, Pawaret Panyajai, Aroonchai Saiai, Methee Rungrojsakul, Singkome Tima, Sawitree Chiampanichayakul, Kankanit Yeerong, Suvimol Somwongin, Wantida Chaiyana, Pornngarm Dejkriengkraikul, Siriporn Okonogi, Trinnakorn Katekunlaphan, Songyot Anuchapreeda

Published in: BMC Complementary Medicine and Therapies | Issue 1/2023

Abstract

Background and aims

The purpose of this study was to investigate the biological properties of Kae-Lae (Maclura cochinchinensis (Lour.) Corner), a traditional medicinal plant used in Ayurvedic recipes in Thailand. To achieve this objective, heartwood samples were collected from 12 sources across Thailand. Fractional extracts (n-hexane, ethyl acetate, and ethanol) and the dominant compounds (morin, resveratrol, and quercetin) were examined for their abilities on cytotoxicity, antioxidant, anti-inflammation, and antileukaemic activity (Wilms’ tumour 1 protein was used as a well-known biomarker for leukaemic cell proliferation).

Methods

The study used MTT to assess cytotoxicity in leukaemic cells (K562, EoL-1, and KG-1a). Antioxidant activities were evaluated using ABTS, DPPH, and FRAP assays. The anti-inflammatory activity was investigated by detecting IL-2, TNF-α, and NO using appropriate detection kits. Wilms’ tumour 1 protein expression was measured by Western blotting to determine the anti-leukaemic activity. The inhibition of cell migration was also analyzed to confirm anticancer progression.

Results

Among the tested extract fraction, ethyl acetate No. 001 displayed strong cytotoxicity specifically in EoL-1 cells, while n-hexane No. 008 demonstrated this effect in three cell lines. Resveratrol, on the other hand, displayed cytotoxicity in all the tested cells. Additionally, the three major compounds, morin, resveratrol, and quercetin, exhibited significant antioxidant and anti-inflammatory properties. In particular, resveratrol demonstrated a noteworthy decreased Wilms’ tumour 1 protein expression and a reduction in cell proliferation across all cells. Moreover, ethyl acetate No. 001, morin, and resveratrol effectively inhibited MCF-7 cell migration. None of these compounds showed any impact on red blood cell haemolysis.

Conclusion

Based on these findings, it can be concluded that Kae-Lae has promising chemotherapeutic potential against leukaemic cells, with fractional extracts (ethyl acetate and n-hexane) and resveratrol exhibiting the most potent cytotoxic, antioxidant, anti-inflammatory, and anti-cell migration activities.

Available only for authorised users

Sato VH, Chewchinda S, Parichatikanond W, Vongsak B. In vitro and in vivo evidence of hypouricemic and anti-inflammatory activities of Maclura cochinchinensis (Lour.) Corner heartwood extract. J Tradit Complement Med. 2020;10(1):85–94.PubMedCrossRef

Leakaya N, Sato VH, Chewchinda S. Antioxidant activity, total phenolic, total flavonoid content and HPTLC analysis of morin in Maclura cochinchinensis heartwood extract. Thai J Pharm Sci. 2018;42:27–41.

Chueahongthong F, Ampasavate C, Okonogi S, Tima S, Anuchapreeda S. Cytotoxic effects of crude kaffir lime (Citrus hystrix, DC.) leaf fractional extracts on leukemic cell lines. J Med Plants Res. 2011;5(14):3097–105.

Butnariu M, Quispe C, Herrera-Bravo J, Pentea M, Sarac I, Küşümler AS, et al. Papaver plants: current insights on phytochemical and nutritional composition along with biotechnological applications. Oxid Med Cell Longev. 2022;2022:2041769.PubMedPubMedCentralCrossRef

Butnariu M, Quispe C, Herrera-Bravo J, Sharifi-Rad J, Singh L, Aborehab NM, et al. The pharmacological activities of Crocus sativus L.: a review based on the mechanisms and therapeutic opportunities of its phytoconstituents. Oxid Med Cell Longev. 2022;2022:8214821.PubMedPubMedCentralCrossRef

Butnariu M, Fernández Ochoa Á, Segura Carretero A, Cádiz Gurrea MdlL. A review on tradescantia: phytochemical constituents, biological activities and health-promoting effects. Front Biosci (Landmark Ed). 2022;27(6):197.PubMedCrossRef

Sarkar D, Fisher PB. Molecular mechanisms of aging-associated inflammation. Cancer Lett. 2006;236(1):13–23. https://doi.org/10.1016/j.canlet.2005.04.009.CrossRefPubMed

Feller N, van der Pol MA, van Stijn A, Weijers GWD, Westra AH, Evertse BW, et al. MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia. Leukemia. 2004;18(8):1380–90.PubMedCrossRef

van Rhenen A, Feller N, Kelder A, Westra AH, Rombouts E, Zweegman S, et al. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival. Clin Cancer Res. 2005;11(18):6520–7. https://doi.org/10.1158/1078-0432.ccr-05-0468.CrossRefPubMed

10.

Lutz C, Woll PS, Hall G, Castor A, Dreau H, Cazzaniga G, et al. Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia. Leukemia. 2013;27(5):1204–7. https://doi.org/10.1038/leu.2012.306.CrossRefPubMed

11.

Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3(7):730–7.PubMedCrossRef

12.

Graham SM, Jørgensen HG, Allan E, Pearson C, Alcorn MJ, Richmond L, et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood. 2002;99(1):319–25.PubMedCrossRef

13.

Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med. 2006;355(12):1253–61. https://doi.org/10.1056/NEJMra061808.CrossRefPubMed

14.

Abdullah LN, Chow EKH. Mechanisms of chemoresistance in cancer stem cells. ClinTransl Med. 2013;2:3.

15.

Panyajai P, Amnajphook N, Keawsangthongcharoen S, Chiampanichayakul S, Tima S, Anuchapreeda S. Study of leukemic stem cell population (CD34+/CD38-) and WT1 protein expression in human leukemic cell lines. Journal of Associated Medical Sciences. 2018;51(1):38–44.

16.

Panyajai P, Tima S, Chiampanichayakul S, Anuchapreeda S. Dietary turmeric bisdemethoxycurcumin suppresses wilms’ tumor 1 and CD34 protein expressions in KG-1a leukemic stem cells. Nutr Cancer. 2019;71(7):1189–200. https://doi.org/10.1080/01635581.2019.1598565.CrossRefPubMed

17.

Busse A, Gökbuget N, Siehl JM, Hoelzer D, Schwartz S, Rietz A, et al. Wilms’ tumor gene 1 (WT1) expression in subtypes of acute lymphoblastic leukemia (ALL) of adults and impact on clinical outcome. Ann Hematol. 2009;88(12):1199–205.PubMedCrossRef

18.

Murata Y, Kudoh T, Sugiyama H, Toyoshima K, Akiyama T. The Wilms tumor suppressor gene WT1 induces G1 arrest and apoptosis in myeloblastic leukemia M1 cells. FEBS Lett. 1997;409(1):41–5.PubMedCrossRef

19.

Olszewski M, Huang W, Chou P, Duerst R, Kletzel M. Wilms’ tumor 1 (WT1) gene in hematopoiesis: a surrogate marker of cell proliferation as a possible mechanism of action? Cytotherapy. 2005;7(1):57–61.PubMed

20.

Barragán E, Cervera J, Bolufer P, Ballester S, Martín G, Fernández P, et al. Prognostic implications of Wilms’ tumor gene (WT1) expression in patients with de novo acute myeloid leukemia. Haematologica. 2004;89(8):926–33.PubMed

21.

Bergmann L, Maurer U, Weidmann E. Wilms tumor gene expression in acute myeloid leukemias. Leuk Lymphoma. 1997;25(5–6):435–43.PubMedCrossRef

22.

Sugiyama H. WT1 (Wilms’ tumor gene 1): biology and cancer immunotherapy. Jpn J Clin Oncol. 2010;40(5):377–87.PubMedCrossRef

23.

Conway O’Brien E, Prideaux S, Chevassut T. The epigenetic landscape of acute myeloid leukemia. Adv Hematol. 2014;2014:103175.PubMedPubMedCentralCrossRef

24.

Lindstedt I, Lindgren MA, Andersson E, Engström W. The WT1 gene–its role in tumourigenesis and prospects for immunotherapeutic advances. In Vivo. 2014;28(5):675–81.PubMed

25.

Rosenfeld C, Cheever M, Gaiger A. WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies. Leukemia. 2003;17(7):1301–12.PubMedCrossRef

26.

Anuchapreeda S, Rungrojsakul M, Tima S, Chiampanichayakul S, Krig SR. Co-activation of WT1 and AP-1 proteins on WT1 gene promoter to induce WT1 gene expression in K562 cells. Cell Signal. 2019;53:339–47. https://doi.org/10.1016/j.cellsig.2018.11.001.CrossRefPubMed

27.

Park C, Lee WS, Go S-I, Nagappan A, Han MH, Hong SH, et al. Morin, a flavonoid from moraceae, induces apoptosis by induction of BAD protein in human leukemic cells. Int J Mol Sci. 2015;16(1):645–59.CrossRef

28.

Pereira WL, de Oliveira TT, Kanashiro MM, Filardi MA, da Costa MR, da Costa LM. Morin exhibits leukemic cellular apoptosis through caspase pathway. Nat Prod Res. 2021;35(23):5554–8.PubMedCrossRef

29.

Kuo H-M, Chang L-S, Lin Y-L, Lu H-F, Yang J-S, Lee J-H, et al. Morin inhibits the growth of human leukemia HL-60 cells via cell cycle arrest and induction of apoptosis through mitochondria dependent pathway. Anticancer Res. 2007;27(1A):395–405.PubMed

30.

Huang X-T, Li X, Xie M-L, Huang Z, Huang Y-X, Wu G-X, et al. Resveratrol: Review on its discovery, anti-leukemia effects and pharmacokinetics. Chem Biol Interact. 2019;306:29–38.PubMedCrossRef

31.

Hu L, Cao D, Li Y, He Y, Guo K. Resveratrol sensitized leukemia stem cell-like KG-1a cells to cytokine-induced killer cells-mediated cytolysis through NKG2D ligands and TRAIL receptors. Cancer Biol Ther. 2012;13(7):516–26.PubMedCrossRef

32.

Wu EJ, Goussetis DJ, Beauchamp E, Kosciuczuk EM, Altman JK, Eklund EA, et al. Resveratrol enhances the suppressive effects of arsenic trioxide on primitive leukemic progenitors. Cancer Biol Ther. 2014;15(4):473–8.PubMedPubMedCentralCrossRef

33.

Lakhanpal P, Rai DK. Quercetin: a versatile flavonoid. Internet Journal of Medical Update. 2007;2(2):22–37.

34.

Shi H, Li X-Y, Chen Y, Zhang X, Wu Y, Wang Z-X et al. Quercetin induces apoptosis via downregulation of vascular endothelial growth factor/akt signaling pathway in acute myeloid leukemia cells. Front Pharmacol. 2020:1972.

35.

He D, Guo X, Zhang E, Zi F, Chen J, Chen Q, et al. Quercetin induces cell apoptosis of myeloma and displays a synergistic effect with dexamethasone in vitro and in vivo xenograft models. Oncotarget. 2016;7(29):45489.PubMedPubMedCentralCrossRef

36.

Naimi A, Entezari A, Hagh MF, Hassanzadeh A, Saraei R, Solali S. Quercetin sensitizes human myeloid leukemia KG-1 cells against TRAIL-induced apoptosis. J Cell Physiol. 2019;234(8):13233–41.PubMedCrossRef

37.

Kongkiatpaiboon S, Tungsukruthai P, Sriyakool K, Pansuksan K, Tunsirikongkon A, Pandith H. Determination of morin in Maclura cochinchinensis heartwood by HPLC. J Chromatogr Sci. 2017;55(3):346–50.PubMed

38.

Chueahongthong F, Tima S, Chiampanichayakul S, Dejkriengkraikul P, Okonogi S, Sasarom M, et al. Doxorubicin-loaded polymeric micelles conjugated with CKR- and EVQ-FLT3 peptides for cytotoxicity in leukemic stem cells. Pharmaceutics. 2022;14(10):2115.PubMedPubMedCentralCrossRef

39.

Viriyaadhammaa N, Duangmano S, Saiai A, Tungjai M, Dejkriengkraikul P, Tima S, et al. A novel drug modulator diarylheptanoid (trans-1,7-Diphenyl-5-hydroxy-1-heptene) from curcuma comosa rhizomes for P-glycoprotein function and apoptosis induction in K652/ADR leukemic cells. Int J Mol Sci. 2022;23(16):8989.PubMedPubMedCentralCrossRef

40.

Viriyaadhammaa N, Saiai A, Neimkhum W, Nirachonkul W, Chaiyana W, Chiampanichayakul S, et al. Cytotoxic and antiproliferative effects of diarylheptanoids isolated from curcuma comosa rhizomes on leukaemic cells. Molecules. 2020;25(22):5476.PubMedPubMedCentralCrossRef

41.

Chaiyana W, Punyoyai C, Somwongin S, Leelapornpisid P, Ingkaninan K, Waranuch N, et al. Inhibition of 5α-reductase, IL-6 secretion, and oxidation process of Equisetum debile Roxb. ex Vaucher extract as functional food and nutraceuticals ingredients. Nutrients. 2017;9(10):1–15.CrossRef

42.

Chaiyana W, Anuchapreeda S, Punyoyai C, Neimkhum W, Lee K-H, Lin W-C, et al. Ocimum sanctum Linn. as a natural source of skin anti-ageing compounds. Ind Crops Prod. 2019;127:217–24.CrossRef

43.

Jadhav R, Patil C, Bhpoe S, Murumkar C. Herbal drug standardization and quality assurance of raw materials: a rational approach. Nat Prod Radiance. 2003;2(3):134–40.

44.

Krishnaiah D, Sarbatly R, Nithyanandam R. A review of the antioxidant potential of medicinal plant species. Food Bioprod Process. 2011;89(C3):217–33. https://doi.org/10.1016/j.fbp.2010.04.008.CrossRef

45.

Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009;7(1):65–74. https://doi.org/10.2174/157015909787602823.CrossRefPubMedPubMedCentral

46.

Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet. 2004;364(9441):1219–28. https://doi.org/10.1016/S0140-6736(04)17138-9.CrossRefPubMed

47.

Jariyawat S, Thammapratip T, Suksen K, Wanitchakool P, Nateewattana J, Chairoungdua A, et al. Induction of apoptosis in murine leukemia by diarylheptanoids from Curcuma comosa Roxb. Cell Biol Toxicol. 2011;27(6):413–23. https://doi.org/10.1007/s10565-011-9196-4.CrossRefPubMed

48.

Leakaya N, Sato VH, Chewchinda S. Antioxidant activity, total phenolic, total flavonoid content and HPTLC analysis of morin in Maclura cochinchinensis heartwood extract. TJPS. 2018;5.

49.

Afsar T, Razak S, Khan MR, Mawash S, Almajwal A, Shabir M, et al. Evaluation of antioxidant, anti-hemolytic and anticancer activity of various solvent extracts of Acacia hydaspica R. Parker aerial parts. BMC Complement Altern Med. 2016;16(1):1–16.CrossRef

50.

Hwang JH, Park SJ, Ko WG, Kang S-M, Lee DB, Bang J, et al. Cordycepin induces human lung cancer cell apoptosis by inhibiting nitric oxide mediated ERK/Slug signaling pathway. Am J Cancer Res. 2017;7(3):417.PubMedPubMedCentral

51.

Weng J-R, Tsai C-H, Kulp SK, Chen C-S. Indole-3-carbinol as a chemopreventive and anti-cancer agent. Cancer Lett. 2008;262(2):153–63. https://doi.org/10.1016/j.canlet.2008.01.033.CrossRefPubMedPubMedCentral

52.

Royston KJ, Tollefsbol TO. The epigenetic impact of cruciferous vegetables on cancer prevention. Curr Pharmacol Rep. 2015;1(1):46–51. https://doi.org/10.1007/s40495-014-0003-9.CrossRefPubMedPubMedCentral

53.

Tortorella SM, Royce SG, Licciardi PV, Karagiannis TC. Dietary sulforaphane in cancer chemoprevention: the role of epigenetic regulation and HDAC inhibition. Antioxid Redox Signal. 2015;22(16):1382–424. https://doi.org/10.1089/ars.2014.6097.CrossRefPubMedPubMedCentral

54.

Mills PK, Beeson WL, Phillips RL, Fraser GE. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer. 1989;64(3):598–604. https://doi.org/10.1002/1097-0142(19890801)64:3%3c598::aid-cncr2820640306%3e3.0.co;2-6.CrossRefPubMed

55.

Holzapfel NP, Holzapfel BM, Champ S, Feldthusen J, Clements J, Hutmacher DW. The potential role of lycopene for the prevention and therapy of prostate cancer: from molecular mechanisms to clinical evidence. Int J Mol Sci. 2013;14(7):14620–46. https://doi.org/10.3390/ijms140714620.CrossRefPubMedPubMedCentral

56.

Bisht K, Choi WH, Park SY, Chung MK, Koh WS. Curcumin enhances non-inflammatory phagocytic activity of RAW264.7 cells. Biochem Biophys Res Commun. 2009;379(2):632–6.PubMedCrossRef

57.

Schwager J, Richard N, Widmer F, Raederstorff D: Resveratrol distinctively modulates the inflammatory profiles of immune and endothelial cells. In: BMC Complement Altern Med. vol. 17: BioMed Central; 2017: 309.

58.

Suganuma M, Sueoka E, Sueoka N, Okabe S, Fujiki H. Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF-α expression. BioFactors. 2000;13(1–4):67–72. https://doi.org/10.1002/biof.5520130112.CrossRefPubMed

59.

Marcotorchino J, Romier B, Gouranton E, Riollet C, Gleize B, Malezet-Desmoulins C, et al. Lycopene attenuates LPS-induced TNF-α secretion in macrophages and inflammatory markers in adipocytes exposed to macrophage-conditioned media. Mol Nutr Food Res. 2012;56(5):725–32. https://doi.org/10.1002/mnfr.201100623.CrossRefPubMed

60.

Makon-Sébastien N, Francis F, Eric S, Henri VP, François LJ, Laurent P, et al. Lycopene modulates THP1 and Caco2 cells inflammatory state through transcriptional and nontranscriptional processes. Mediators Inflamm. 2014;2014:507272.PubMedPubMedCentralCrossRef

61.

Carter LG, D'Orazio JA, Pearson KJ: Resveratrol and cancer: focus on in vivo evidence. In: Endocr Relat Cancer. vol. 21: Bioscientifica Ltd; 2014: R209–25.

62.

Ko J-H, Sethi G, Um J-Y, Shanmugam MK, Arfuso F, Kumar AP et al: The role of resveratrol in cancer therapy. In: Int J Mol Sci. vol. 18: MDPI; 2017: 2589.

63.

Ruhee RT, Ma S, Suzuki K. Sulforaphane protects cells against lipopolysaccharide-stimulated inflammation in murine macrophages. Antioxidants (Basel). 2019;8(12):577. https://doi.org/10.3390/antiox8120577.CrossRefPubMed

64.

Lin W, Wu RT, Wu T, Khor T-O, Wang H, Kong A-N. Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochem Pharmacol. 2008;76(8):967–73. https://doi.org/10.1016/j.bcp.2008.07.036.CrossRefPubMedPubMedCentral

65.

Anuchapreeda S, Khumpirapang N, Rupitiwiriya K, Tho-iam L, Saiai A, Okonogi S, et al. Cytotoxicity and inhibition of leukemic cell proliferation by sesquiterpenes from rhizomes of Mah-Lueang (Curcuma cf. viridiflora Roxb.). Bioorg Med Chem Lett. 2018;28(3):410–4.PubMedCrossRef

66.

Anuchapreeda S, Tima S, Duangrat C, Limtrakul P. Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines. Cancer Chemother Pharmacol. 2008;62(4):585–94. https://doi.org/10.1007/s00280-007-0642-1.CrossRefPubMed

67.

Lee KS, Lee MG, Nam KS. Evaluation of the antimetastatic and anticancer activities of morin in HER2 overexpressing breast cancer SKBR3 cells. Oncol Rep. 2021;46(1):126.PubMedCrossRef

68.

Tang FY, Su YC, Chen NC, Hsieh HS, Chen KS. Resveratrol inhibits migration and invasion of human breast-cancer cells. Mol Nutr Food Res. 2008;52(6):683–91.PubMedCrossRef

Title: Biological activities of extracts and compounds from Thai Kae-Lae (Maclura cochinchinensis (Lour.) Corner)
Authors: Lapamas Rueankham
Pawaret Panyajai
Aroonchai Saiai
Methee Rungrojsakul
Singkome Tima
Sawitree Chiampanichayakul
Kankanit Yeerong
Suvimol Somwongin
Wantida Chaiyana
Pornngarm Dejkriengkraikul
Siriporn Okonogi
Trinnakorn Katekunlaphan
Songyot Anuchapreeda
Publication date: 01-12-2023
Publisher: BioMed Central
Keyword: Leukemia
Published in: BMC Complementary Medicine and Therapies / Issue 1/2023
Electronic ISSN: 2662-7671
DOI: https://doi.org/10.1186/s12906-023-03979-w

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Biological activities of extracts and compounds from Thai Kae-Lae (Maclura cochinchinensis (Lour.) Corner)

Abstract

Background and aims

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background and aims

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2023

The effect of an adapted Mindfulness-Based Stress Reduction program on mental health, maternal bonding and birth outcomes in psychosocially vulnerable pregnant women: a study protocol for a randomized controlled trial in a Danish hospital-based outpatient setting

Anti-colorectal cancer of Ardisia gigantifolia Stapf. and targets prediction via network pharmacology and molecular docking study

Mechanisms of action of Fu Fang Gang Liu liquid in treating condyloma acuminatum by network pharmacology and experimental validation

Protective effecs of baicalin magnesium on non-alcoholic steatohepatitis rats are based on inhibiting NLRP3/Caspase-1/IL-1β signaling pathway

Isolation and identification of active ingredients and biological activity of Dioscorea nipponica Makino

Some new insights into the biological activities of carboxymethylated polysaccharides from Lasiodiplodia theobromae